Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936598 · ClinicalTrials.gov registry record · NA
Sleep and Endometrial Cancer
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00936598 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 6 participants.
The verdict
NCT00936598, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study proposes to test the hypothesis that zolpidem taken the night before major surgery for endometrial cancer will improve sleep efficiency and reduce post surgery pain, as well as reduce the need for analgesic medication.
Interventions
- DRUG sugar pill
- DRUG zolpidem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00936598
The ClinicalTrials.gov registry entry for NCT00936598 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sugar pill is the first listed.
NCT00936598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00936598 about?
NCT00936598 is a clinical study titled "Sleep and Endometrial Cancer". This study proposes to test the hypothesis that zolpidem taken the night before major surgery for endometrial cancer will improve sleep efficiency and reduce post surgery pain, as well as reduce the need for analgesic medication.
What is the current status of trial NCT00936598?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2009-07. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00936598?
The interventions under investigation include: sugar pill (DRUG), zolpidem (DRUG).
Who is sponsoring clinical trial NCT00936598?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.